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d~fferent marl'fade Of indu¢IKm, AF i ~  by Bu and A show ~lim~lar mod~r- 
ate conslMency of shod.tem~ actNMton o~mctlon whah differs mafkeofy from 
VF, 3) Geometric or n~¢han~st~ ffemraes may b~ respon~l~o for these 
of~mwal~r~. 
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Wh~ I1~ o!oatmde~ ol lwo m~als am i~ced m co.act ~th tm~., an ~lec- 
t~  Curr~t m prnducecl lt~l m diW¢lly pmport~tal to me lemperal~m ~l ih~ 
o~1~ m m o f ~  o ~ ~ .  B~-~ bedew ce~ cumin1 roaches 
a maximum level to,owed ~ a ¢ l~e t~om the steep n~e in impeda,¢= 
is seen~ .. ' !~  eR~mmeflt was ¢~f~' r~ to ¢~erve IP.e lemPeralum at whah 
I t~ occ'w~ and to eva~uate whemer ma~ c~t ot~Put pmdCm l~mn 
ton~a~m. 
AAk~to¢ls: A ~.F EPT cal~tm w~t a ~ motm/e~ on the l~p o! a 
4 mm distal ete¢'Wode was u~JL Fre=h bovine ~ myoca~um was 
~ a lemperam~ -~,'~ed ~ web o ~ g  b~ne I~od. In 
the flint ~:~ce~, rad~ole~lueeay (RF) eeer~ was ~ at a coneumt kwel 
of 3or. RF ~bon ~ ~led  whe~ ce~ output decreased below 
20% ol ~ bi~-battefy level. In the e~o~o,-,6 protocol, RF energy was rinsed 
m a Slep w~e ~ ~11~t t!,Be w~ a steep nse m impedanca. Lesmns 
were measured ~ m,~l were ~mmed ~ mWo t~e l~razol i~, A tofal 
Of 12 e ~  al~Ik~Itiorts were m~ti~. 
Resu~: 1"he temperetum at mmamum b~0~Im,eW cen oulput was 70_8 
± 3.8~'C ~lth born l~otocols and them was a linear con~ation between the 
cell ~0~tage and ~ mem~lor temperature (~ = 0-96 -+ 0.02). Ma~irm.,m cell 
outpuUoltowed by a 20% drop. resulted m lesion fom~atmn at all lhe ablatmn 
s~les with mean les~on ~ of 6.5 ,~ 5.4 ,, 5.4 mm (length ,, molh ,, 
G~13th) and ~rere was no dlfferenoB in MS~I s~e Jn U1ese two pretoo01s. 
~ :  Mmomum bio-bage~ cell output pmdicts lesmn ~rma~.  
Maxmaum cell voflage may be used to ~ a feeat~ack loop to decrease 
the RF energy level to prevent issue chamng and ra~ m,t~nce nse. 
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Backgtout~: The gcal of maze prOcedure is to prevent atnal libnlla~on but 
allow sinus impulses to propagate via an isthmus, wh:.ch connects ~qable atnal 
tissues. The size and structure of [sthmus asseoated w~th th,s destrabte ffect 
remain unclear. 
Methods: Endocard~al isthmuses ot decreasing sizes |2. 1 and 0.5 cm) 
were created in five isolated and perfused canine nght atha (3.8 by 32 cm) 
in the presence Of 1-5 uM of ACh The cuts spared the -¢p~rd~um. "['he 
tissues were paced at increasing rates from either site of the isthmus, and 
the resultant actwation Pagem was mapped from the opmardium using 477 
bipolar electrodes (1,6 mm apart. 
Resu/ts: With istt,muses 2 & ~ cm wide, regular pacing at Ct of 150 ms 
from either st(~e of the cut allowed impulses to conduct to the other side 
across the isthmus. Rapid pacing could induce either multiple WFs wdh 
"fibrillation'-type activity, or single stationary RWF (CL: 106 ± 17 ms) with 
"flutter'-type activity. Both types of WFs were able to propagate across the 
isthmus. With an isthmus of 0.5 cm. only single stationary RWF with a longer 
CL (138 ± 23 ms, p < 0.05) could be induced. This RWF consistently failed to 
propagate across the isthmus, while paced WFs could conduct in 1:1 fashion 
down to CL of 140--160 ms (n = 3) with pectinate muscle (PM) in the isthmus. 
or to CL of 250-300 ms (n = 2) without PM in the isthmus. 
Conclusmns: An endocardial isthmus of 0.5 cm prevents the propagation 
of RWFs and the generation of multiple WFs, while allowing paced WFs to 
conduct. The presence of PM in the isthmus increases the safety factor for 
impulse propagation at regular pacing. 
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Background: An animal model of nght atrial pacing in order to study atrial 
t~brlllat~'~ (AF) is widely used. but the m~cl~amsm~ of ~ aevelopmem of 
a rtwemble ainal myopathy am IPOO~ly uederstoo~ We hypothes~e that a 
d*ffemnt degm~ of o~pers~n Of refr~Pc1onre~s and vul~erat~hly for t ~  
Of no~suslaine~ AF between tml~¢u!ated (T} and smooth ngh~ atrium (SR&) 
may conthbuto lo ,~t~atmn and m~inter~mce of AF 
Me~PIO<~: In 12 Ilealtlly ¢ ~  mong~ do~ weq~ ~.4  ¢ 1 
k(~ Pm0r~ ~la f ie~ w~ p e ~  hem ~ t r~ O~ me TRA aee ~ 
on 1~.~ SRA, A pmmat, m b¢~l w~ m t ~  L~m~P4! m ~ ~ .  m 
10 ~ Steps tml~t ~ m ~ e l  IERP) w~ ~ ~ a 
mA. AF vtdner~ility ~mt~n (VUL) w~ d~dte~ ~, th~ ietew=d betwe~ fire 
~z :  Them w~m ~ ~,~-~',,~1 ~ ~ pa~ng ~ be. 
tv,~ee~ TRA a~l SPA (0.~ :~ 0,25 V~ 0,33 ~: 0.24 ~) .  
(ERP (m) 97z 17 t00~25 ~t  t4 ~a~ 
~'D IEflP (m~s) 17 ~. 5" 25 ± 6" 14 ¢ 5' ~ ~: 7' 
AF VI~L (ms) ~ t ;~'§ 42 "~ 29' ;~3 ~- 21"r~ 35 t ;~5" 
SD = ~ o n ;  ', t = p ~ 005; " = p -~ 0.01 
Cotc/t~o~: The e~mmn of retrectonnees i w~er, and the ~ 1 ~  
for ir1£hCtlOrl 0t AF is mcreal~ on the sn~.  as conlt~lred to th~ trabGcL~ 
lated R~ ~ n y  ®nag Cow paang trees. ~ ~ may co~m1~te 
1o initiatmn and maintenance d AFm the canine model of rap~l RA pacing. 
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Response in IJhe MUSTT Trial 
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Back~:~nd. Patients (pts) ~ drug tetraclop/ventricutar ~fdm (VT) 
are at high risk for sustained arthylhrnzas and death. However, the clmmal 
charactenst¢~ which pmdct the ~ to anPa~,c  de.~e are 
well descnbed. 
Methods: We analysed pts in the MUSTT study rano~mtzed to antiarrhyth- 
mm therapy. All pls had coronary disease, an electron fraction (EF) -~0,40, 
unsuStained VT and reducible sustained VT or f~bnllatwno (VF) 
Results: There were t27 drug responders (38%} ol the 330 pCs tested, Of 
the responders. 88 (6EP~,) were suppressed ~ the first randorr~zed rug 
rested. The rP'Juct~on of VF at baseline was associated wdh a higher response 
rate than the mductson o! mortomoq~ VT (6"P/,, v~ 34%, p = 0.001), and 
the med~n cycle length of monomoq~c VT was shorter in res~,~rs  man 
non.responders (240 v.~ 2-30 ms, p = 0,025), ~ r .  din~al o'larac~l'~t~ 
such as age, gender, El:. I~eart a~re (CHF). previous revasculanzaflon or 
exfent of coronary d~sease ~ not predat <~Kj re~:~-,se (p's > 0,05). 
R ~  Nent'e,monde~ 
Age lye) 68 67 
Gender (%male) 9,4 8¢3 
EF O30 0.30 
CHF J,%) 67 80 
Conclusmn: The ino'uoble rhythm, but not clinical charactertst=cs, orrelate 
with antiarrhylmic drug response in this population 
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Pts with CAD. poor LV function and unsustained VT are at a higher risk of 
death when sustained ventricular arrhylhm,a is inducible and non-suppress- 
ible at electmphysiology study (EPS). The assooation between •e method 
of induction, the nature of the induced VTNF & the outcome has not been 
studied. We used the MADIT database to compare survwors (n = 142) with 
cardiac deaths (n = 38), and pts with defibrillators who never received shocks 
(n = 40) to those who did (n = 62) over 1.-61 me. {mean 27) 
